Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine
Shengju Wang, Xu Zhang, Baochao Cai, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2020) Vol. 21, Iss. 6, pp. 971-979
Closed Access | Times Cited: 25

Showing 25 citing articles:

The chemistry of heterocycles in the 21st century
Valery N. Charushin, Egor V. Verbitskiy, О. Н. Чупахин, et al.
Russian Chemical Reviews (2024) Vol. 93, Iss. 7, pp. RCR5125-RCR5125
Closed Access | Times Cited: 35
Berberine ameliorates depression‐like behavior in CUMS mice by activating TPH1 and inhibiting IDO1‐associated with tryptophan metabolism
Pingyuan Ge, Shu‐Yue Qu, Sai‐jia Ni, et al.
Phytotherapy Research (2022) Vol. 37, Iss. 1, pp. 342-357
Closed Access | Times Cited: 36
The mechanism of berberine alleviating metabolic disorder based on gut microbiome
Han Wang, Haiyu Zhang, Zezheng Gao, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 33
Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer’s Disease
Mingzhenlong Deng, Wanli Yan, Zhicheng Gu, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1486-1486
Open Access | Times Cited: 17
Research Progress on Neuroprotective Effects of Isoquinoline Alkaloids
Jinhua Li, Yarong Wu, Shuze Dong, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4797-4797
Open Access | Times Cited: 15
Berberine as a Potential Agent for the Treatment of Colorectal Cancer
Xi Jiang, Zhongxiu Jiang, Min Jiang, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 21
The circadian rhythm: A new target of natural products that can protect against diseases of the metabolic system, cardiovascular system, and nervous system
Meiling Xin, Fangjie Bi, Chao Wang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 4
Shenlian Decoction Ameliorates LPS‐Related Inflammation in db/db Mice: Coupling Network Pharmacology With Experimental Verification
Yifan Liu, Yuan-yuan Liu, Yao Xiao, et al.
Journal of Diabetes Research (2025) Vol. 2025, Iss. 1
Open Access
Zhuyu pill attenuates metabolic-associated fatty liver disease by regulating macrophage polarization through TLR4 signaling pathway
Mei Zhao, Qingman He, Xinyao Shu, et al.
Phytomedicine (2025), pp. 156439-156439
Open Access
Mitigating the Coffee-Ring effect exhibited by pesticide solutions on pepper leaves using amphiphilic berberine sulfate microgels
Shuangli Zhang, Jingmei Li, Lifang Lei, et al.
Chemical Engineering Journal (2025), pp. 160513-160513
Closed Access
Managing Irinotecan-Induced Diarrhea: A Comprehensive Review of Therapeutic Interventions in Cancer Treatment
Xiaoqin Yang, Jiamei Chen, Yitao Wang, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 359-359
Open Access
Berberine: an isoquinoline alkaloid targeting the oxidative stress and gut-brain axis in the models of depression
Cong-Ya Chen, Yi Zhang
European Journal of Medicinal Chemistry (2025), pp. 117475-117475
Closed Access
c-MYC and HIF1α promoter G-quadruplexes dependent metabolic regulation mechanism of berberine in colon cancer
Lina Wen, Zongqiang Han, Jianhui Li, et al.
Journal of Gastrointestinal Oncology (2022) Vol. 13, Iss. 3, pp. 1152-1168
Open Access | Times Cited: 16
Tianhuang formula ameliorates liver fibrosis by inhibiting CCL2-CCR2 axis and MAPK/NF-κB signaling pathway
Tian Lan, Bo Chen, X. Hu, et al.
Journal of Ethnopharmacology (2023) Vol. 321, pp. 117516-117516
Closed Access | Times Cited: 10
Shenlian (SL) Decoction, a Traditional Chinese Medicine Compound, May Ameliorate Blood Glucose via Mediating the Gut Microbiota in db/db Mice
Ruixi Sun, Weijun Huang, Yao Xiao, et al.
Journal of Diabetes Research (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 15
Multi-target regulation of intestinal microbiota by berberine to improve type 2 diabetes mellitus
Qiongyao He, Hui Dong, Yujin Guo, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 14
Traditional Chinese medicines (TCMs) with varied meridians (Gui-Jing) differentially alleviate the adverse impact of Coptis chinensis on gut microbiota
Yanan Yang, Wenquan Su, Chenchen Zang, et al.
Journal of Ethnopharmacology (2023) Vol. 307, pp. 116256-116256
Closed Access | Times Cited: 7
Development of an Innovative Berberine Food-Grade Formulation with an Ameliorated Absorption: In Vitro Evidence Confirmed by Healthy Human Volunteers Pharmacokinetic Study
Giovanna Petrangolini, Fabrizio Corti, M Ronchi, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 14
Network Pharmacology and Bioinformatics Methods Reveal the Mechanism of Berberine in the Treatment of Ischaemic Stroke
Ke Song, Yikun Sun, Haoqi Liu, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 9
Comprehensive insights into berberine's hypoglycemic mechanisms: A focus on ileocecal microbiome in db/db mice
Xuan Chen, Xi-yu Mei, Zeming Ren, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33704-e33704
Open Access | Times Cited: 1
Discovery of the First in Class 9-N-Berberine Derivative as Hypoglycemic Agent with Extra-Strong Action
Михаил В. Хвостов, Elizaveta D. Gladkova, С. А. Борисов, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2138-2138
Open Access | Times Cited: 8
The Pathogenic Role of Foam Cells in Atherogenesis: Do They Represent Novel Therapeutic Targets?
Giuseppe Lisco, Vito Angelo Giagulli, Giovanni De Pergola, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2022) Vol. 22, Iss. 7, pp. 765-777
Closed Access | Times Cited: 4
Simultaneous Improvements of Physicochemical Properties and Anti‐Microbial Activity of Berberine via Forming Salt with Gallic Acid
Yi Chen, Xirui Yang, Guolian Ren, et al.
Crystal Research and Technology (2024) Vol. 59, Iss. 4
Closed Access
Exploring the protective effects of herbal monomers against diabetic retinopathy based on the regulation of autophagy and apoptosis: A review
Zhuoyu Hu, Xuan Wang, Qi Hu, et al.
Medicine (2023) Vol. 102, Iss. 43, pp. e35541-e35541
Open Access | Times Cited: 1
Investigating the Mechanism of Rhizoma Coptidis-Eupatorium fortunei Medicine in the Treatment of Type 2 Diabetes Based on Network Pharmacology and Molecular Docking
Huan Li, Dan Luo, Ran Wei, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 2
Page 1

Scroll to top